Company Filing History:
Years Active: 2014-2015
Title: The Innovative Mind of Miguel Angel Pena-Piñón
Introduction
Miguel Angel Pena-Piñón is a notable inventor based in Toledo, Spain. He has made significant contributions to the field of pharmaceuticals with a focus on neurological and psychiatric disorders. With two patents to his name, Pena-Piñón's work embodies the essence of innovation in medical science, leveraging his expertise to address complex health issues.
Latest Patents
Miguel Angel Pena-Piñón's latest patents center on "Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors." These inventions pertain to compounds that serve as positive allosteric modulators for the metabotropic glutamate receptor subtype 5 (mGluR5). The patent details synthetic methods for creating these compounds, their pharmaceutical compositions, and their application in treating neurological and psychiatric disorders linked with glutamate dysfunction. The abstracts of these patents serve as scanning tools for further research and innovation in this field.
Career Highlights
Pena-Piñón is currently affiliated with Vanderbilt University, where he collaborates with other leading researchers in the area of glutamate receptor modulation. His career reflects a dedication to advancing pharmaceutical science and improving therapeutic strategies for mental health conditions.
Collaborations
In his journey as an inventor, Miguel Angel Pena-Piñón has worked closely with esteemed colleagues, including P Jeffrey Conn and Craig William Lindsley. These collaborations emphasize the interdisciplinary approach essential for tackling the complexities of neurological research and discovering new treatment modalities.
Conclusion
Miguel Angel Pena-Piñón stands out as an impactful inventor whose work in pharmaceutical innovation has the potential to transform the treatment landscape for neurological and psychiatric disorders. With his cutting-edge patents and collaborative spirit, he continues to contribute significantly to scientific advancements that will benefit patients worldwide.